Favipiravir in SARS-CoV-2 Infection: Is it Worth it?
Comb Chem High Throughput Screen
; 25(14): 2413-2428, 2022.
Article
in En
| MEDLINE
| ID: mdl-35430987
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Viruses
/
COVID-19 Drug Treatment
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
Comb Chem High Throughput Screen
Journal subject:
BIOLOGIA MOLECULAR
/
QUIMICA
Year:
2022
Document type:
Article
Affiliation country:
Egypt
Country of publication:
United Arab Emirates